Aboody, K. S.; Brown, A.; Rainov, N. G.; Bower, K. A.; Liu, S.; Yang, W.; Small, J. E.; Herrlinger, U.; Ourednik, V.; Black, P. M.; Breakefield, X. O. und Snyder, E. Y. (2000): Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas, Proc Natl Acad Sci U S A 97) [23], Seite 12846-51.

Aebersold, P.; Hyatt, C.; Johnson, S.; Hines, K.; Korcak, L.; Sanders, M.; Lotze, M.; Topalian, S.; Yang, J. und Rosenberg, S. A. (1991): Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response, J Natl Cancer Inst 83) [13], Seite 932-7.

Akamatsu, Y.; Murphy, J. C.; Nolan, K. F.; Thomas, P.; Kreitman, R. J.; Leung, S. O. und Junghans, R. P. (1998): A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells, Clin Cancer Res 4) [11], Seite 2825-32.

Altenschmidt, U.; Kahl, R.; Moritz, D.; Schnierle, B. S.; Gerstmayer, B.; Wels, W. und Groner, B. (1996): Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes, Clin Cancer Res 2) [6], Seite 1001-8.

Altenschmidt, U.; Klundt, E. und Groner, B. (1997): Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression, J Immunol 159) [11], Seite 5509-15.

Amiot, L.; Onno, M.; Drenou, B.; Monvoisin, C. und Fauchet, R. (1998): HLA-G class I gene expression in normal and malignant hematopoietic cells, Hum Immunol 59) [8], Seite 524-8..

Amiot, L.; Onno, M.; Renard, I.; Drenou, B.; Guillaudeux, T.; Le Bouteiller, P. und Fauchet, R. (1996): HLA-G transcription studies during the different stages of normal and malignant hematopoiesis, Tissue Antigens 48) [5], Seite 609-14..

Anand, N. N.; Mandal, S.; MacKenzie, C. R.; Sadowska, J.; Sigurskjold, B.; Young, N. M.; Bundle, D. R. und Narang, S. A. (1991): Bacterial expression and secretion of various single-chain Fv genes encoding proteins specific for a Salmonella serotype B O-antigen, J Biol Chem 266) [32], Seite 21874-9.

Annenkov, A. E.; Moyes, S. P.; Eshhar, Z.; Mageed, R. A. und Chernajovsky, Y. (1998): Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit, J Immunol 161) [12], Seite 6604-13.

Arakawa, F.; Shibaguchi, H.; Xu, Z. und Kuroki, M. (2002): Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activity, Anticancer Res 22) [6C], Seite 4285-9.

Arase, H.; Arase, N. und Saito, T. (1995): Fas-mediated cytotoxicity by freshly isolated natural killer cells, J Exp Med 181) [3], Seite 1235-8.

Asano, R.; Takemura, S.; Tsumoto, K.; Sakurai, N.; Teramae, A.; Ebara, S.; Katayose, Y.; Shinoda, M.; Suzuki, M.; Imai, K.; Matsuno, S.; Kudo, T. und Kumagai, I. (2000): Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system, J Biochem (Tokyo) 127) [4], Seite 673-9..

Assenmacher, M. (1992): Combined intracellular and surface staining, Radbruch, A., Flow cytometry and cell sorting, 1. Auflage, Seite 59-64, Springer Verlag, Berlin, Heidelberg, Leipzig, New York.

Atkinson, T. P.; Hall, C. G.; Goldsmith, J. und Kirkham, P. M. (2003): Splice variant in TCRzeta links T cell receptor signaling to a G-protein-related signaling pathway, Biochem Biophys Res Commun 310) [3], Seite 761-6.

Atwell, J. L.; Breheney, K. A.; Lawrence, L. J.; McCoy, A. J.; Kortt, A. A. und Hudson, P. J. (1999): scFv multimers of the anti-neuraminidase antibody Nc10: length of the linker between Vh and Vl domains dictates precisely the transition between diabodies and triabodies, Protein Eng 12) [7], Seite 597-604.

Awwad, M. und North, R. J. (1988): Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy- resistant tumour. Evidence that Cy permits the expression of adoptive T- cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden, Immunology 65) [1], Seite 87-92..

Azuma, M.; Cayabyab, M.; Buck, D.; Phillips, J. H. und Lanier, L. L. (1992): Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line, J Immunol 149) [4], Seite 1115-23.

Bakker, A. B.; Wu, J.; Phillips, J. H. und Lanier, L. L. (2000): NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals, Hum Immunol 61) [1], Seite 18-27.

Batge, B.; Bosslet, K.; Sedlacek, H. H.; Kern, H. F. und Kloppel, G. (1986): Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias, Virchows Arch A Pathol Anat Histopathol 408) [4], Seite 361-74.

Batra, J. K.; FitzGerald, D.; Gately, M.; Chaudhary, V. K. und Pastan, I. (1990): Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells, J Biol Chem 265) [25], Seite 15198-202.

Baum, R. P.; Hertel, A.; Lorenz, M.; Schwarz, A.; Encke, A. und Hor, G. (1989): 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results, Nucl Med Commun 10) [5], Seite 345-52.

Baum, R. P.; Lorenz, M.; Hertel, A.; Baew Christow, T.; Schwarz, A. und Hor, G. (1989): Erfolgreiche immunszintigraphische Tumordetektion mit Technetium-99m-markierten monoklonalen Anti-CEA-Antikorpern. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies], Onkologie 12), Seite 126-9.

Beauchemin, N.; Draber, P.; Dveksler, G.; Gold, P.; Gray-Owen, S.; Grunert, F.; Hammarstrom, S.; Holmes, K. V.; Karlsson, A.; Kuroki, M.; Lin, S. H.; Lucka, L.; Najjar, S. M.; Neumaier, M.; Obrink, B.; Shively, J. E.; Skubitz, K. M.; Stanners, C. P.; Thomas, P.; Thompson, J. A.; Virji, M.; von Kleist, S.; Wagener, C.; Watt, S. und Zimmermann, W. (1999): Redefined nomenclature for members of the carcinoembryonic antigen family, Exp Cell Res 252) [2], Seite 243-9..

Beecham, E. J.; Ortiz Pujols, S. und Junghans, R. P. (2000): Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor, J Immunother 23) [3], Seite 332-43.

Belardelli, F.; Ferrantini, M.; Proietti, E. und Kirkwood, J. M. (2002): Interferon-alpha in tumor immunity and immunotherapy, Cytokine Growth Factor Rev 13) [2], Seite 119-34.

Bennett, M.; Yu, Y. Y.; Stoneman, E.; Rembecki, R. M.; Mathew, P. A.; Lindahl, K. F. und Kumar, V. (1995): Hybrid resistance: 'negative' and 'positive' signaling of murine natural killer cells, Semin Immunol 7) [2], Seite 121-7.

Biassoni, R.; Bottino, C.; Millo, R.; Moretta, L. und Moretta, A. (1999): Natural killer cell-mediated recognition of human trophoblast, Semin Cancer Biol 9) [1], Seite 13-8..

Biassoni, R.; Pessino, A.; Malaspina, A.; Cantoni, C.; Bottino, C.; Sivori, S.; Moretta, L. und Moretta, A. (1997): Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules, Eur J Immunol 27) [12], Seite 3095-9.

Bird, R. E.; Hardman, K. D.; Jacobson, J. W.; Johnson, S.; Kaufman, B. M.; Lee, S. M.; Lee, T.; Pope, S. H.; Riordan, G. S. und Whitlow, M. (1988): Single-chain antigen-binding proteins, Science 242) [4877], Seite 423-6.

Bochan, M. R.; Goebel, W. S. und Brahmi, Z. (1995): Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability, Cell Immunol 164) [2], Seite 234-9..

Boeckmann, W.; Baum, R. P.; Schuldes, H.; Kramer, W.; Hertel, A.; Baew Christow, T.; Hanke, P.; Jonas, D. und Hor, G. (1990): Tumour imaging of bladder carcinomas and their metastases with 111indium-labelled monoclonal anti-CEA antibody BW 431/26, Br J Cancer Suppl 4), Seite 1081-4.

Bordignon, C.; Carlo-Stella, C.; Colombo, M. P.; De Vincentiis, A.; Lanata, L.; Lemoli, R. M.; Locatelli, F.; Olivieri, A.; Rondelli, D.; Zanon, P. und Tura, S. (1999): Cell therapy: achievements and perspectives, Haematologica 84) [12], Seite 1110-49.

Boshoff, C. und Weiss, R. (2002): AIDS-related malignancies, Nat Rev Cancer 2) [5], Seite 373-82..

Bosslet, K.; Czech, J.; Lorenz, P.; Sedlacek, H. H.; Schuermann, M. und Seemann, G. (1992): Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation, Br J Cancer 65) [2], Seite 234-8.

Bosslet, K.; Luben, G.; Schwarz, A.; Hundt, E.; Harthus, H. P.; Seiler, F. R.; Muhrer, C.; Kloppel, G.; Kayser, K. und Sedlacek, H. H. (1985): Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA), Int J Cancer 36) [1], Seite 75-84.

Bosslet, K.; Steinstrasser, A.; Schwarz, A.; Harthus, H. P.; Luben, G.; Kuhlmann, L. und Sedlacek, H. H. (1988): Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas, Eur J Nucl Med 14) [11], Seite 523-8.

Bothmann, H. und Pluckthun, A. (2000): The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines, J Biol Chem 275) [22], Seite 17100-5.

Bottino, C.; Castriconi, R.; Pende, D.; Rivera, P.; Nanni, M.; Carnemolla, B.; Cantoni, C.; Grassi, J.; Marcenaro, S.; Reymond, N.; Vitale, M.; Moretta, L.; Lopez, M. und Moretta, A. (2003): Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule, J Exp Med 198) [4], Seite 557-67.

Boucher, D.; Cournoyer, D.; Stanners, C. P. und Fuks, A. (1989): Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue, Cancer Res 49) [4], Seite 847-52..

Breitling, F. und Dübel, S. (1997): Rekombinante Antikörper, Labor im Focus, Spektrum Akademischer Verlag, Heidelberg, Berlin, 3-8274-0029-5.

Brekken, R. A. und Thorpe, P. E. (2001): VEGF-VEGF receptor complexes as markers of tumor vascular endothelium, J Control Release 74) [1-3], Seite 173-81..

Brocker, T. (2000): Chimeric Fv-zeta or Fv-epsilon receptors are not sufficient to induce activation or cytokine production in peripheral T cells, Blood 96) [5], Seite 1999-2001.

Brumbaugh, K. M.; Binstadt, B. A.; Billadeau, D. D.; Schoon, R. A.; Dick, C. J.; Ten, R. M. und Leibson, P. J. (1997): Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity, J Exp Med 186) [12], Seite 1965-74..

Brumbaugh, K. M.; Perez-Villar, J. J.; Dick, C. J.; Schoon, R. A.; Lopez-Botet, M. und Leibson, P. J. (1996): Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses, J Immunol 157) [7], Seite 2804-12..

Brutkiewicz, R. R. und Sriram, V. (2002): Natural killer T (NKT) cells and their role in antitumor immunity, Crit Rev Oncol Hematol 41) [3], Seite 287-98.

Bruynck, A.; Seemann, G. und Bosslet, K. (1993): Characterisation of a humanised bispecific monoclonal antibody for cancer therapy, Br J Cancer 67) [3], Seite 436-40.

Bukowski, R. M.; Rayman, P.; Uzzo, R.; Bloom, T.; Sandstrom, K.; Peereboom, D.; Olencki, T.; Budd, G. T.; McLain, D.; Elson, P.; Novick, A. und Finke, J. H. (1998): Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy, Clin Cancer Res 4) [10], Seite 2337-47..

Burchard, G. D.; Moslein, C. und Brattig, N. W. (1992): Adherence between Entamoeba histolytica trophozoites and undifferentiated or DMSO-induced HL-60 cells, Parasitol Res 78) [4], Seite 336-40.

Burke, J. M.; Jurcic, J. G. und Scheinberg, D. A. (2002): Radioimmunotherapy for acute leukemia, Cancer Control 9) [2], Seite 106-13..

Burnet, F. M. (1970): The concept of immunological surveillance, Prog Exp Tumor Res 13), Seite 1-27.

Calogero, A.; de Leij, L. F.; Mulder, N. H. und Hospers, G. A. (2000): Recombinant T-cell receptors: an immunologic link to cancer therapy, J Immunother 23) [4], Seite 393-400.

Campbell, B. J.; Finnie, I. A.; Hounsell, E. F. und Rhodes, J. M. (1995): Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin, J Clin Invest 95) [2], Seite 571-6.

Cao, Y.; Karsten, U. R.; Liebrich, W.; Haensch, W.; Springer, G. F. und Schlag, P. M. (1995): Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluation, Cancer 76) [10], Seite 1700-8.

Caron, P. C.; Dumont, L. und Scheinberg, D. A. (1998): Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia, Clin Cancer Res 4) [6], Seite 1421-8.

Caron, P. C.; Jurcic, J. G.; Scott, A. M.; Finn, R. D.; Divgi, C. R.; Graham, M. C.; Jureidini, I. M.; Sgouros, G.; Tyson, D.; Old, L. J. und et al. (1994): A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity, Blood 83) [7], Seite 1760-8..

Caron, P. C.; Lai, L. T. und Scheinberg, D. A. (1995): Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia, Clin Cancer Res 1) [1], Seite 63-70.

Caron, P. C. und Scheinberg, D. A. (1993): Anti-CD33 monoclonal antibody M195 for the therapy of myeloid leukemia, Leuk Lymphoma 11 Suppl 2), Seite 1-6.

Carretero, M.; Llano, M.; Navarro, F.; Bellon, T. und Lopez-Botet, M. (2000): Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E, Eur J Immunol 30) [10], Seite 2842-8..

Cervantes, F.; Pierson, B. A.; McGlave, P. B.; Verfaillie, C. M. und Miller, J. S. (1996): Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture, Blood 87) [6], Seite 2476-85.

Cesano, A.; Pierson, G.; Visonneau, S.; Migliaccio, A. R. und Santoli, D. (1996): Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets, Blood 87) [1], Seite 393-403.

Cesano, A.; Visonneau, S.; Jeglum, K. A.; Owen, J.; Wilkinson, K.; Carner, K.; Reese, L. und Santoli, D. (1996): Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumors, Cancer Res 56) [13], Seite 3021-9..

Cesano, A.; Visonneau, S.; Pasquini, S.; Rovera, G. und Santoli, D. (1996): Antitumor efficacy of a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in immunocompetent mice bearing syngeneic leukemia, Cancer Res 56) [19], Seite 4444-52.

Cesano, A.; Visonneau, S.; Rovera, G. und Santoli, D. (1997): Synergistic effects of adriamycin and TALL-104 cell therapy against a human gastric carcinoma in vivo, Anticancer Res 17) [3C], Seite 1887-92..

Cesano, A.; Visonneau, S. und Santoli, D. (1998): TALL-104 cell therapy of human solid tumors implanted in immunodeficient (SCID) mice, Anticancer Res 18) [4A], Seite 2289-95.

Cesano, A.; Visonneau, S.; Tran, T. und Santoli, D. (1999): Biodistribution of human MHC non-restricted TALL-104 killer cells in healthy and tumor bearing mice, Int J Oncol 14) [2], Seite 245-51.

Cesano, A.; Visonneau, S.; Wolfe, J. H.; Jeglum, K. A.; Fernandez, J.; Gillio, A.; O'Reilly, R. J. und Santoli, D. (1997): Toxicological and immunological evaluation of the MHC-non-restricted cytotoxic T cell line TALL-104, Cancer Immunol Immunother 44) [3], Seite 125-36.

Challita-Eid, P. M.; Abboud, C. N.; Morrison, S. L.; Penichet, M. L.; Rosell, K. E.; Poles, T.; Hilchey, S. P.; Planelles, V. und Rosenblatt, J. D. (1998): A RANTES-antibody fusion protein retains antigen specificity and chemokine function, J Immunol 161) [7], Seite 3729-36.

Chaudhary, V. K.; Queen, C.; Junghans, R. P.; Waldmann, T. A.; FitzGerald, D. J. und Pastan, I. (1989): A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin, Nature 339) [6223], Seite 394-7.

Chen, C. J.; Li, L. J.; Maruya, A. und Shively, J. E. (1995): In vitro and in vivo footprint analysis of the promoter of carcinoembryonic antigen in colon carcinoma cells: effects of interferon gamma treatment, Cancer Res 55) [17], Seite 3873-82..

Chen, W. S.; Kitson, R. P. und Goldfarb, R. H. (2002): Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1), In Vivo 16) [6], Seite 439-45.

Chen, Y. T.; Scanlan, M. J.; Sahin, U.; Tureci, O.; Gure, A. O.; Tsang, S.; Williamson, B.; Stockert, E.; Pfreundschuh, M. und Old, L. J. (1997): A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening, Proc Natl Acad Sci U S A 94) [5], Seite 1914-8..

Chiesa, M. D.; Vitale, M.; Carlomagno, S.; Ferlazzo, G.; Moretta, L. und Moretta, A. (2003): The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors, Eur J Immunol 33) [6], Seite 1657-66.

Choo, A. B.; Dunn, R. D.; Broady, K. W. und Raison, R. L. (2002): Soluble expression of a functional recombinant cytolytic immunotoxin in insect cells, Protein Expr Purif 24) [3], Seite 338-47..

Chothia, C. und Lesk, A. M. (1987): Canonical structures for the hypervariable regions of immunoglobulins, J Mol Biol 196) [4], Seite 901-17.

Chothia, C.; Lesk, A. M.; Tramontano, A.; Levitt, M.; Smith-Gill, S. J.; Air, G.; Sheriff, S.; Padlan, E. A.; Davies, D.; Tulip, W. R. und et al. (1989): Conformations of immunoglobulin hypervariable regions, Nature 342) [6252], Seite 877-83.

Chuang, S. S.; Kim, M. H.; Johnson, L. A.; Albertsson, P.; Kitson, R. P.; Nannmark, U.; Goldfarb, R. H. und Mathew, P. A. (2000): 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness, Immunology 100) [3], Seite 378-83..

Chuang, S. S.; Kumaresan, P. R. und Mathew, P. A. (2001): 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways, J Immunol 167) [11], Seite 6210-6..

Chung, S.; Wucherpfennig, K. W.; Friedman, S. M.; Hafler, D. A. und Strominger, J. L. (1994): Functional three-domain single-chain T-cell receptors, Proc Natl Acad Sci U S A 91) [26], Seite 12654-8.

Chung, Y. S.; Yamashita, Y.; Kato, Y.; Nakata, B.; Sawada, T. und Sowa, M. (1996): Prognostic significance of T antigen expression in patients with gastric carcinoma, Cancer 77) [9], Seite 1768-73.

Clark, M. R. (1997): IgG effector mechanisms, Chem Immunol 65), Seite 88-110.

Collins, S. J.; Ruscetti, F. W.; Gallagher, R. E. und Gallo, R. C. (1978): Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds, Proc Natl Acad Sci U S A 75) [5], Seite 2458-62..

Collins, S. J.; Ruscetti, F. W.; Gallagher, R. E. und Gallo, R. C. (1979): Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide, J Exp Med 149) [4], Seite 969-74..

Condra, J. H.; Sardana, V. V.; Tomassini, J. E.; Schlabach, A. J.; Davies, M. E.; Lineberger, D. W.; Graham, D. J.; Gotlib, L. und Colonno, R. J. (1990): Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells, J Biol Chem 265) [4], Seite 2292-5.

Cordon Cardo, C.; Fuks, Z.; Drobnjak, M.; Moreno, C.; Eisenbach, L. und Feldman, M. (1991): Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas, Cancer Res 51) [23 Pt 1], Seite 6372-80.

Cornil, I.; Kerbel, R. S. und Dennis, J. W. (1990): Tumor cell surface beta 1-4-linked galactose binds to lectin(s) on microvascular endothelial cells and contributes to organ colonization, J Cell Biol 111) [2], Seite 773-81.

Correa, M. R.; Ochoa, A. C.; Ghosh, P.; Mizoguchi, H.; Harvey, L. und Longo, D. L. (1997): Sequential development of structural and functional alterations in T cells from tumor-bearing mice, J Immunol 158) [11], Seite 5292-6..

Cosman, D.; Mullberg, J.; Sutherland, C. L.; Chin, W.; Armitage, R.; Fanslow, W.; Kubin, M. und Chalupny, N. J. (2001): ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor, Immunity 14) [2], Seite 123-33..

Daly, T.; Royal, R. E.; Kershaw, M. H.; Treisman, J.; Wang, G.; Li, W.; Herlyn, D.; Eshhar, Z. und Hwu, P. (2000): Recognition of human colon cancer by T cells transduced with a chimeric receptor gene, Cancer Gene Ther 7) [2], Seite 284-91.

Davis, G. T.; Bedzyk, W. D.; Voss, E. W. und Jacobs, T. W. (1991): Single chain antibody (SCA) encoding genes: one-step construction and expression in eukaryotic cells, Biotechnology (N Y) 9) [2], Seite 165-9.

Deaglio, S.; Zubiaur, M.; Gregorini, A.; Bottarel, F.; Ausiello, C. M.; Dianzani, U.; Sancho, J. und Malavasi, F. (2002): Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells, Blood 99) [7], Seite 2490-8..

Degreve, B.; De Clercq, E. und Balzarini, J. (1999): Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues, Gene Ther 6) [2], Seite 162-70.

Deng, S. J.; MacKenzie, C. R.; Sadowska, J.; Michniewicz, J.; Young, N. M.; Bundle, D. R. und Narang, S. A. (1994): Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display, J Biol Chem 269) [13], Seite 9533-8.

Djeu, J. Y.; Jiang, K. und Wei, S. (2002): A view to a kill: signals triggering cytotoxicity, Clin Cancer Res 8) [3], Seite 636-40..

Duenas, M.; Vazquez, J.; Ayala, M.; Soderlind, E.; Ohlin, M.; Perez, L.; Borrebaeck, C. A. und Gavilondo, J. V. (1994): Intra- and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins, Biotechniques 16) [3], Seite 476-7, 480-3..

Dunn, G. P.; Bruce, A. T.; Ikeda, H.; Old, L. J. und Schreiber, R. D. (2002): Cancer immunoediting: from immunosurveillance to tumor escape, Nat Immunol 3) [11], Seite 991-8.

Dutcher, J. (2002): Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma, Oncology (Huntingt) 16) [11 Suppl 13], Seite 4-10.

Ebert, O.; Finke, S.; Salahi, A.; Herrmann, M.; Trojaneck, B.; Lefterova, P.; Wagner, E.; Kircheis, R.; Huhn, D.; Schriever, F. und Schmidt-Wolf, I. G. (1997): Lymphocyte apoptosis: induction by gene transfer techniques, Gene Ther 4) [4], Seite 296-302..

Eischen, C. M.; Woo, D.; Roussel, M. F. und Cleveland, J. L. (2001): Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis, Mol Cell Biol 21) [15], Seite 5063-70..

Engels, B.; Cam, H.; Schuler, T.; Indraccolo, S.; Gladow, M.; Baum, C.; Blankenstein, T. und Uckert, W. (2003): Retroviral vectors for high-level transgene expression in T lymphocytes, Hum Gene Ther 14) [12], Seite 1155-68.

Eshhar, Z. (1997): Tumor-specific T-bodies: towards clinical application, Cancer Immunol Immunother 45) [3-4], Seite 131-6.

Eshhar, Z.; Bach, N.; Fitzer-Attas, C. J.; Gross, G.; Lustgarten, J.; Waks, T. und Schindler, D. G. (1996): The T-body approach: potential for cancer immunotherapy, Springer Semin Immunopathol 18) [2], Seite 199-209.

Eshhar, Z.; Waks, T.; Bendavid, A. und Schindler, D. G. (2001): Functional expression of chimeric receptor genes in human T cells, J Immunol Methods 248) [1-2], Seite 67-76..

Eshhar, Z.; Waks, T.; Gross, G. und Schindler, D. G. (1993): Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors, Proc Natl Acad Sci U S A 90) [2], Seite 720-4.

Farson, D.; McGuinness, R.; Dull, T.; Limoli, K.; Lazar, R.; Jalali, S.; Reddy, S.; Pennathur-Das, R.; Broad, D. und Finer, M. (1999): Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols, J Gene Med 1) [3], Seite 195-209..

Feng, Y. Q.; Lorincz, M. C.; Fiering, S.; Greally, J. M. und Bouhassira, E. E. (2001): Position effects are influenced by the orientation of a transgene with respect to flanking chromatin, Mol Cell Biol 21) [1], Seite 298-309..

Ferlazzo, G.; Spaggiari, G. M.; Semino, C.; Melioli, G. und Moretta, L. (2000): Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors, Eur J Immunol 30) [3], Seite 827-33..

Fernandez, L. A. und de Lorenzo, V. (2001): Formation of disulphide bonds during secretion of proteins through the periplasmic-independent type I pathway, Mol Microbiol 40) [2], Seite 332-46..

Ferrara, N. (1996): Natural killer cells, adhesion and tumor angiogenesis, Nat Med 2) [9], Seite 971-2.

Finer, M. H.; Dull, T. J.; Qin, L.; Farson, D. und Roberts, M. R. (1994): kat: a high-efficiency retroviral transduction system for primary human T lymphocytes, Blood 83) [1], Seite 43-50.

Finke, J.; Ferrone, S.; Frey, A.; Mufson, A. und Ochoa, A. (1999): Where have all the T cells gone? Mechanisms of immune evasion by tumors, Immunol Today 20) [4], Seite 158-60. 00001435 00001435.

Fitzer Attas, C. J.; Schindler, D. G.; Waks, T. und Eshhar, Z. (1997): Direct T cell activation by chimeric single chain Fv-Syk promotes Syk-Cbl association and Cbl phosphorylation, J Biol Chem 272) [13], Seite 8551-7.

Fitzer Attas, C. J.; Schindler, D. G.; Waks, T. und Eshhar, Z. (1998): Harnessing Syk family tyrosine kinases as signaling domains for chimeric single chain of the variable domain receptors: optimal design for T cell activation, J Immunol 160) [1], Seite 145-54.

Fox, B. A.; Spiess, P. J.; Kasid, A.; Puri, R.; Mule, J. J.; Weber, J. S. und Rosenberg, S. A. (1990): In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes, J Biol Response Mod 9) [5], Seite 499-511.

Foy, S. P. und Matsuuchi, L. (2001): Association of B lymphocyte antigen receptor polypeptides with multiple chaperone proteins, Immunol Lett 78) [3], Seite 149-60.

Frangsmyr, L.; Baranov, V. und Hammarstrom, S. (1999): Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat, Tumour Biol 20) [5], Seite 277-92..

Freeman, S. D.; Kelm, S.; Barber, E. K. und Crocker, P. R. (1995): Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules, Blood 85) [8], Seite 2005-12..

Freund, C.; Ross, A.; Guth, B.; Pluckthun, A. und Holak, T. A. (1993): Characterization of the linker peptide of the single-chain Fv fragment of an antibody by NMR spectroscopy, FEBS Lett 320) [2], Seite 97-100.

Gahmberg, C. G.; Valmu, L.; Fagerholm, S.; Kotovuori, P.; Ihanus, E.; Tian, L. und Pessa-Morikawa, T. (1998): Leukocyte integrins and inflammation, Cell Mol Life Sci 54) [6], Seite 549-55..

Galandrini, R.; Palmieri, G.; Piccoli, M.; Frati, L. und Santoni, A. (1999): Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity, J Immunol 162) [6], Seite 3148-52..

Gao, G. und Goldfarb, M. (1995): Heparin can activate a receptor tyrosine kinase, Embo J 14) [10], Seite 2183-90.

Gao, L.; Yang, T. H.; Tourdot, S.; Sadovnikova, E.; Hasserjian, R. und Stauss, H. J. (1999): Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease, Blood 94) [9], Seite 2999-3006..

Garcia-Lora, A.; Algarra, I. und Garrido, F. (2003): MHC class I antigens, immune surveillance, and tumor immune escape, J Cell Physiol 195) [3], Seite 346-55.

Garrick, D.; Sutherland, H.; Robertson, G. und Whitelaw, E. (1996): Variegated expression of a globin transgene correlates with chromatin accessibility but not methylation status, Nucleic Acids Res 24) [24], Seite 4902-9..

Garrido, F.; Cabrera, T.; Lopez Nevot, M. A. und Ruiz Cabello, F. (1995): HLA class I antigens in human tumors, Adv Cancer Res, Seite 67155-95.

Gastman, B. R.; Atarshi, Y.; Reichert, T. E.; Saito, T.; Balkir, L.; Rabinowich, H. und Whiteside, T. L. (1999): Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes, Cancer Res 59) [20], Seite 5356-64..

George, T.; Yu, Y. Y.; Liu, J.; Davenport, C.; Lemieux, S.; Stoneman, E.; Mathew, P. A.; Kumar, V. und Bennett, M. (1997): Allorecognition by murine natural killer cells: lysis of T-lymphoblasts and rejection of bone-marrow grafts, Immunol Rev 155), Seite 29-40.

Ghosh, P.; Komschlies, K. L.; Cippitelli, M.; Longo, D. L.; Subleski, J.; Ye, J.; Sica, A.; Young, H. A.; Wiltrout, R. H. und Ochoa, A. C. (1995): Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth, J Natl Cancer Inst 87) [19], Seite 1478-83..

Giralt, S. A. und Kolb, H. J. (1996): Donor lymphocyte infusions, Curr Opin Oncol 8) [2], Seite 96-102..

Gismondi, A.; Morrone, S.; Humphries, M. J.; Piccoli, M.; Frati, L. und Santoni, A. (1991): Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin, J Immunol 146) [1], Seite 384-92.

Gladow, M.; Uckert, W. und Blankenstein, T. (2004): Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors, Eur J Immunol 34) [7], Seite 1882-91.

Glockshuber, R.; Malia, M.; Pfitzinger, I. und Pluckthun, A. (1990): A comparison of strategies to stabilize immunoglobulin Fv-fragments, Biochemistry 29) [6], Seite 1362-7.

Goldberger, A.; Middleton, K. A. und Newman, P. J. (1994): Changes in expression of the cell adhesion molecule PECAM-1 (CD31) during differentiation of human leukemic cell lines, Tissue Antigens 44) [5], Seite 285-93..

Gorochov, G.; Lustgarten, J.; Waks, T.; Gross, G. und Eshhar, Z. (1992): Functional assembly of chimeric T-cell receptor chains, Int J Cancer Suppl 7), Seite 53-7.

Goverman, J.; Gomez, S. M.; Segesman, K. D.; Hunkapiller, T.; Laug, W. E. und Hood, L. (1990): Chimeric immunoglobulin-T cell receptor proteins form functional receptors: implications for T cell receptor complex formation and activation, Cell 60) [6], Seite 929-39.

Gowans, J. L. und Uhr, J. W. (1966): The carriage of immunological memory by small lymphocytes in the rat, J Exp Med 124) [5], Seite 1017-30..

Gratama, J. W.; Zea, A. H.; Bolhuis, R. L. und Ochoa, A. C. (1999): Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy, Cancer Immunol Immunother 48) [5], Seite 263-9..

Griep, R. A.; van Twisk, C.; Kerschbaumer, R. J.; Harper, K.; Torrance, L.; Himmler, G.; van der Wolf, J. M. und Schots, A. (1999): pSKAP/S: An expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins, Protein Expr Purif 16) [1], Seite 63-9..

Griffioen, A. W.; Coenen, M. J.; Damen, C. A.; Hellwig, S. M.; van Weering, D. H.; Vooys, W.; Blijham, G. H. und Groenewegen, G. (1997): CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells, Blood 90) [3], Seite 1150-9..

Griffioen, A. W.; Damen, C. A.; Blijham, G. H. und Groenewegen, G. (1996): Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium, Blood 88) [2], Seite 667-73..

Gross, G.; Waks, T. und Eshhar, Z. (1989): Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity, Proc Natl Acad Sci U S A 86) [24], Seite 10024-8.

Gubler, U. und Hoffman, B. J. (1983): A simple and very efficient method for generating cDNA libraries, Gene 25) [2-3], Seite 263-9.

Gumperz, J. E.; Barber, L. D.; Valiante, N. M.; Percival, L.; Phillips, J. H.; Lanier, L. L. und Parham, P. (1997): Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor, J Immunol 158) [11], Seite 5237-41.

Gussow, D. und Seemann, G. (1991): Humanization of monoclonal antibodies, Methods Enzymol 203), Seite 99-121.

Hacein-Bey-Abina, S.; Von Kalle, C.; Schmidt, M.; McCormack, M. P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C. S.; Pawliuk, R.; Morillon, E.; Sorensen, R.; Forster, A.; Fraser, P.; Cohen, J. I.; de Saint Basile, G.; Alexander, I.; Wintergerst, U.; Frebourg, T.; Aurias, A.; Stoppa-Lyonnet, D.; Romana, S.; Radford-Weiss, I.; Gross, F.; Valensi, F.; Delabesse, E.; Macintyre, E.; Sigaux, F.; Soulier, J.; Leiva, L. E.; Wissler, M.; Prinz, C.; Rabbitts, T. H.; Le Deist, F.; Fischer, A. und Cavazzana-Calvo, M. (2003): LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1, Science 302) [5644], Seite 415-9.

Hammarstrom, S. (1999): The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues, Semin Cancer Biol 9) [2], Seite 67-81..

Hanahan, D. (1985): DNA Cloning 1, Glover, D., IRL Press Ltd., London.

Hanson, H. L.; Donermeyer, D. L.; Ikeda, H.; White, J. M.; Shankaran, V.; Old, L. J.; Shiku, H.; Schreiber, R. D. und Allen, P. M. (2000): Eradication of established tumors by CD8+ T cell adoptive immunotherapy, Immunity 13) [2], Seite 265-76..

Hansson, M.; Jonsson, S.; Persson, A. M.; Calafat, J.; Tapper, H. und Olsson, I. (2003): Targeting proteins to secretory lysosomes of natural killer cells as a principle for immunoregulation, Mol Immunol 40) [6], Seite 363-72.

Haynes, N. M.; Smyth, M. J.; Kershaw, M. H.; Trapani, J. A. und Darcy, P. K. (1999): Fas-ligand-mediated lysis of erbB-2-expressing tumour cells by redirected cytotoxic T lymphocytes, Cancer Immunol Immunother 47) [5], Seite 278-86..

Haynes, N. M.; Snook, M. B.; Trapani, J. A.; Cerruti, L.; Jane, S. M.; Smyth, M. J. und Darcy, P. K. (2001): Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma, J Immunol 166) [1], Seite 182-7.

Haynes, N. M.; Trapani, J. A.; Teng, M. W.; Jackson, J. T.; Cerruti, L.; Jane, S. M.; Kershaw, M. H.; Smyth, M. J. und Darcy, P. K. (2002): Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation, J Immunol 169) [10], Seite 5780-6.

Haynes, N. M.; Trapani, J. A.; Teng, M. W.; Jackson, J. T.; Cerruti, L.; Jane, S. M.; Kershaw, M. H.; Smyth, M. J. und Darcy, P. K. (2002): Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors, Blood 100) [9], Seite 3155-63.

Heiskala, M. K.; Patarroyo, M. und Timonen, T. T. (1990): Participation of CD11a-c/CD18 and RGD-recognizing adhesion molecules in the binding of LGL to fibroblasts. Evidence for the role of CD11a in the fibroblast-mediated inactivation of NK cells, Scand J Immunol 32) [2], Seite 137-47..

Herberman, R. B.; Holden, H. T.; Ting, C. C.; Lavrin, D. L. und Kirchner, H. (1976): Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice, Cancer Res 36) [2 pt 2], Seite 615-21.

Hertel, A.; Baum, R. P.; Lorenz, M.; Baew Christow, T.; Encke, A. und Hor, G. (1990): Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA, Br J Cancer Suppl 6), Seite 1034-6.

Hinnen, A.; Hicks, J. B. und Fink, G. R. (1978): Transformation of yeast, Proc Natl Acad Sci U S A 75) [4], Seite 1929-33.

Hombach, A.; Heuser, C.; Gerken, M.; Fischer, B.; Lewalter, K.; Diehl, V.; Pohl, C. und Abken, H. (2000): T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition, Gene Ther 7) [12], Seite 1067-75.

Hombach, A.; Heuser, C.; Marquardt, T.; Wieczarkowiecz, A.; Groneck, V.; Pohl, C. und Abken, H. (2001): Cd4(+) t cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a mhc antigen- and fas-independent fashion, J Immunol 167) [2], Seite 1090-6..

Hombach, A.; Heuser, C.; Sircar, R.; Tillmann, T.; Diehl, V.; Kruis, W.; Pohl, C. und Abken, H. (1997): T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope, Gastroenterology 113) [4], Seite 1163-70.

Hombach, A.; Heuser, C.; Sircar, R.; Tillmann, T.; Diehl, V.; Pohl, C. und Abken, H. (1998): An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30, Cancer Res 58) [6], Seite 1116-9.

Hombach, A.; Koch, D.; Sircar, R.; Heuser, C.; Diehl, V.; Kruis, W.; Pohl, C. und Abken, H. (1999): A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA, Gene Ther 6) [2], Seite 300-4.

Hombach, A.; Muche, J. M.; Gerken, M.; Gellrich, S.; Heuser, C.; Pohl, C.; Sterry, W. und Abken, H. (2001): T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells, Gene Ther 8) [11], Seite 891-5..

Hombach, A.; Schneider, C.; Sent, D.; Koch, D.; Willemsen, R. A.; Diehl, V.; Kruis, W.; Bolhuis, R. L.; Pohl, C. und Abken, H. (2000): An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells, Int J Cancer 88) [1], Seite 115-20.

Hombach, A.; Sent, D.; Schneider, C.; Heuser, C.; Koch, D.; Pohl, C.; Seliger, B. und Abken, H. (2001): T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis, Cancer Res 61) [5], Seite 1976-82..

Hombach, A.; Sircar, R.; Heuser, C.; Tillmann, T.; Diehl, V.; Kruis, W.; Pohl, C. und Abken, H. (1998): Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and gamma or zeta signalling chains, Int J Mol Med 2) [1], Seite 99-103.

Honegger, A. und Pluckthun, A. (2001): Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool, J Mol Biol 309) [3], Seite 657-70.

Horowitz, M. M.; Gale, R. P.; Sondel, P. M.; Goldman, J. M.; Kersey, J.; Kolb, H. J.; Rimm, A. A.; Ringden, O.; Rozman, C.; Speck, B. und et al. (1990): Graft-versus-leukemia reactions after bone marrow transplantation, Blood 75) [3], Seite 555-62..

Hu, J.; Kindsvogel, W.; Busby, S.; Bailey, M. C.; Shi, Y. Y. und Greenberg, P. D. (1993): An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues, J Exp Med 177) [6], Seite 1681-90..

Hudson, P. J. und Kortt, A. A. (1999): High avidity scFv multimers; diabodies and triabodies, J Immunol Methods 231) [1-2], Seite 177-89.

Huston, J. S.; McCartney, J.; Tai, M. S.; Mottola-Hartshorn, C.; Jin, D.; Warren, F.; Keck, P. und Oppermann, H. (1993): Medical applications of single-chain antibodies, Int Rev Immunol 10) [2-3], Seite 195-217.

Hwu, P.; Shafer, G. E.; Treisman, J.; Schindler, D. G.; Gross, G.; Cowherd, R.; Rosenberg, S. A. und Eshhar, Z. (1993): Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain, J Exp Med 178) [1], Seite 361-6.

Hwu, P.; Yang, J. C.; Cowherd, R.; Treisman, J.; Shafer, G. E.; Eshhar, Z. und Rosenberg, S. A. (1995): In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes, Cancer Res 55) [15], Seite 3369-73.

Hwu, P.; Yannelli, J.; Kriegler, M.; Anderson, W. F.; Perez, C.; Chiang, Y.; Schwarz, S.; Cowherd, R.; Delgado, C.; Mule, J. und et al. (1993): Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans, J Immunol 150) [9], Seite 4104-15.

Ito, W.; Iba, Y. und Kurosawa, Y. (1993): Effects of substitutions of closely related amino acids at the contact surface in an antigen-antibody complex on thermodynamic parameters, J Biol Chem 268) [22], Seite 16639-47.

Jensen, M. C.; Clarke, P.; Tan, G.; Wright, C.; Chung-Chang, W.; Clark, T. N.; Zhang, F.; Slovak, M. L.; Wu, A. M.; Forman, S. J. und Raubitschek, A. (2000): Human T lymphocyte genetic modification with naked DNA, Mol Ther 1) [1], Seite 49-55..

Jensen, M. C.; Cooper, L. J.; Wu, A. M.; Forman, S. J. und Raubitschek, A. (2003): Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy, Cytotherapy 5) [2], Seite 131-8.

Jewett, A. (2001): Activation of c-Jun N-terminal kinase in the absence of NFkappaB function prior to induction of NK cell death triggered by a combination of anti-class I and anti-CD16 antibodies, Hum Immunol 62) [4], Seite 320-31..

Jiang, K.; Zhong, B.; Gilvary, D. L.; Corliss, B. C.; Hong-Geller, E.; Wei, S. und Djeu, J. Y. (2000): Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells, Nat Immunol 1) [5], Seite 419-25..

Jiang, Y. Z.; Kanfer, E. J.; Macdonald, D.; Cullis, J. O.; Goldman, J. M. und Barrett, A. J. (1991): Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells, Bone Marrow Transplant 8) [4], Seite 253-8..

Johnson, L. A.; Goldfarb, R. H. und Mathew, P. A. (2000): Regulation of IFN-gamma production following 2B4 activation in human NK cells, In Vivo 14) [5], Seite 625-9..

Jost, C. R.; Kurucz, I.; Jacobus, C. M.; Titus, J. A.; George, A. J. und Segal, D. M. (1994): Mammalian expression and secretion of functional single-chain Fv molecules, J Biol Chem 269) [42], Seite 26267-73.

Jung, S. H.; Pastan, I. und Lee, B. (1994): Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3, Proteins 19) [1], Seite 35-47.

Jurcic, J. G. (2000): Antibody therapy of acute myelogenous leukemia, Cancer Biother Radiopharm 15) [4], Seite 319-26..

Jurcic, J. G. (2001): Antibody therapy for residual disease in acute myelogenous leukemia, Crit Rev Oncol Hematol 38) [1], Seite 37-45..

Jurcic, J. G.; Larson, S. M.; Sgouros, G.; McDevitt, M. R.; Finn, R. D.; Divgi, C. R.; Ballangrud, A. M.; Hamacher, K. A.; Ma, D.; Humm, J. L.; Brechbiel, M. W.; Molinet, R. und Scheinberg, D. A. (2002): Targeted alpha particle immunotherapy for myeloid leukemia, Blood 100) [4], Seite 1233-9..

Kabat, E.A.; Wu, T.T.; Reid-Miller, M.; Perry, H.M. und Gottesman, K.S. (1987): Sequences of Proteins of Immunological Interest., 4. Auflage, US Department of Health Human Services, Washington, DC.

Kansas, G. S.; Muirhead, M. J. und Dailey, M. O. (1990): Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans, Blood 76) [12], Seite 2483-92..

Karre, K. (1995): Express yourself or die: peptides, MHC molecules, and NK cells, Science 267) [5200], Seite 978-9.

Kataoka, T.; Schroter, M.; Hahne, M.; Schneider, P.; Irmler, M.; Thome, M.; Froelich, C. J. und Tschopp, J. (1998): FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation, J Immunol 161) [8], Seite 3936-42.

Kato, T.; Sato, K.; Suzuki, S.; Sasakawa, H.; Kurokawa, M.; Nishioka, K. und Yamamoto, K. (1995): Mammalian expression of single chain variable region fragments dimerized by Fc regions, Mol Biol Rep 21) [3], Seite 141-6.

Kawata, A.; Hosokawa, M.; Sawamura, Y.; Ito, K.; Une, Y.; Shibata, T.; Uchino, J. und Kobayashi, H. (1990): Modification of lymphokine-activated killer cell accumulation into tumor sites by chemotherapy, local irradiation, or splenectomy, Mol Biother 2) [4], Seite 221-7..

Kawata, A.; Une, Y.; Hosokawa, M.; Wakizaka, Y.; Namieno, T.; Uchino, J. und Kobayashi, H. (1995): Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin alone, Am J Clin Oncol 18) [3], Seite 257-62..

Kazemier, B.; de Haard, H.; Boender, P.; van Gemen, B. und Hoogenboom, H. (1996): Determination of active single chain antibody concentrations in crude periplasmic fractions, J Immunol Methods 194) [2], Seite 201-9.

Kelly, J. M.; Darcy, P. K.; Markby, J. L.; Godfrey, D. I.; Takeda, K.; Yagita, H. und Smyth, M. J. (2002): Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection, Nat Immunol 3) [1], Seite 83-90..

Kershaw, M. H.; Westwood, J. A. und Hwu, P. (2002): Dual-specific T cells combine proliferation and antitumor activity, Nat Biotechnol 20) [12], Seite 1221-7.

Kershaw, M. H.; Westwood, J. A.; Zhu, Z.; Witte, L.; Libutti, S. K. und Hwu, P. (2000): Generation of gene-modified T cells reactive against the angiogenic kinase insert domain-containing receptor (KDR) found on tumor vasculature, Hum Gene Ther 11) [18], Seite 2445-52.

Khan, W. N.; Frangsmyr, L.; Teglund, S.; Israelsson, A.; Bremer, K. und Hammarstrom, S. (1992): Identification of three new genes and estimation of the size of the carcinoembryonic antigen family, Genomics 14) [2], Seite 384-90..

King, A.; Hiby, S. E.; Gardner, L.; Joseph, S.; Bowen, J. M.; Verma, S.; Burrows, T. D. und Loke, Y. W. (2000): Recognition of trophoblast HLA class I molecules by decidual NK cell receptors--a review, Placenta 21 Suppl A), Seite S81-5..

Kinugasa, T.; Kuroki, M.; Takeo, H.; Matsuo, Y.; Ohshima, K.; Yamashita, Y.; Shirakusa, T. und Matsuoka, Y. (1998): Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas, Int J Cancer 76) [1], Seite 148-53..

Kipriyanov, S. M.; Kupriyanova, O. A.; Little, M. und Moldenhauer, G. (1996): Rapid detection of recombinant antibody fragments directed against cell- surface antigens by flow cytometry, J Immunol Methods 196) [1], Seite 51-62.

Kipriyanov, S. M.; Moldenhauer, G. und Little, M. (1997): High level production of soluble single chain antibodies in small-scale Escherichia coli cultures, J Immunol Methods 200) [1-2], Seite 69-77.

Kipriyanov, S. M.; Moldenhauer, G.; Martin, A. C.; Kupriyanova, O. A. und Little, M. (1997): Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity, Protein Eng 10) [4], Seite 445-53.

Kipriyanov, S. M.; Moldenhauer, G.; Strauss, G. und Little, M. (1998): Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells, Int J Cancer 77) [5], Seite 763-72.

Kleber Janke, T. und Becker, W. M. (2000): Use of modified BL21(DE3) Escherichia coli cells for high-level expression of recombinant peanut allergens affected by poor codon usage, Protein Expr Purif 19) [3], Seite 419-24.

Klingemann, H. G. und Miyagawa, B. (1996): Purging of malignant cells from blood after short ex vivo incubation with NK-92 cells, Blood 87) [11], Seite 4913-4.

Klingemann, H. G.; Wong, E. und Maki, G. (1996): A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood, Biol Blood Marrow Transplant 2) [2], Seite 68-75.

Knarr, G.; Gething, M. J.; Modrow, S. und Buchner, J. (1995): BiP binding sequences in antibodies, J Biol Chem 270) [46], Seite 27589-94.

Knazek, R. A.; Wu, Y. W.; Aebersold, P. M. und Rosenberg, S. A. (1990): Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors, J Immunol Methods 127) [1], Seite 29-37..

Koduri, R. K.; Miller, J. T. und Thammana, P. (2001): An efficient homologous recombination vector pTV(I) contains a hot spot for increased recombinant protein expression in Chinese hamster ovary cells, Gene 280) [1-2], Seite 87-95.

Kogure, K.; Urabe, M.; Mizukami, H.; Kume, A.; Sato, Y.; Monahan, J. und Ozawa, K. (2001): Targeted integration of foreign DNA into a defined locus on chromosome 19 in K562 cells using AAV-derived components, Int J Hematol 73) [4], Seite 469-75..

Kontermann, R. E.; Liu, Z.; Schulze, R. A.; Sommer, K. A.; Queitsch, I.; Dubel, S.; Kipriyanov, S. M.; Breitling, F. und Bautz, E. K. (1995): Characterization of the epitope recognized by a monoclonal antibody directed against the largest subunit of Drosophila RNA polymerase II, Biol Chem Hoppe-Seyler 376) [8], Seite 473-81.

Kossman, S. E.; Scheinberg, D. A.; Jurcic, J. G.; Jimenez, J. und Caron, P. C. (1999): A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia, Clin Cancer Res 5) [10], Seite 2748-55.

Kretzschmar, T.; Aoustin, L.; Zingel, O.; Marangi, M.; Vonach, B.; Towbin, H. und Geiser, M. (1996): High-level expression in insect cells and purification of secreted monomeric single-chain Fv antibodies, J Immunol Methods 195) [1-2], Seite 93-101.

Krop-Watorek, A.; Oikawa, S.; Oyama, Y. und Nakazato, H. (1998): Oligomerization of N-terminal domain of carcinoembryonic antigen (CEA) expressed in Escherichia coli, Biochem Biophys Res Commun 242) [1], Seite 79-83..

Kubin, M.; Cassiano, L.; Chalupny, J.; Chin, W.; Cosman, D.; Fanslow, W.; Mullberg, J.; Rousseau, A. M.; Ulrich, D. und Armitage, R. (2001): ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells, Eur J Immunol 31) [5], Seite 1428-37..

Kuroki, M.; Arakawa, F.; Yamamoto, H.; Shimura, H.; Ikehara, Y. und Matsuoka, Y. (1988): Active production and membrane anchoring of carcinoembryonic antigen observed in normal colon mucosa, Cancer Lett 43) [1-2], Seite 151-7..

Laemmli, U. K. (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227) [259], Seite 680-5.

Lal, S.; Lauer, U. M.; Niethammer, D.; Beck, J. F. und Schlegel, P. G. (2000): Suicide genes: past, present and future perspectives, Immunol Today 21) [1], Seite 48-54..

Lang, S.; Vujanovic, N. L.; Wollenberg, B. und Whiteside, T. L. (1998): Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells, Eur J Immunol 28) [3], Seite 780-6.

Lanier, L. L.; Spits, H. und Phillips, J. H. (1992): The developmental relationship between NK cells and T cells, Immunol Today 13) [10], Seite 392-5.

Leitzgen, K.; Knittler, M. R. und Haas, I. G. (1997): Assembly of immunoglobulin light chains as a prerequisite for secretion. A model for oligomerization-dependent subunit folding, J Biol Chem 272) [5], Seite 3117-23.

Leong, S. P.; Zhou, Y. M.; Granberry, M. E.; Wang, T. F.; Grogan, T. M.; Spier, C.; White, R.; Mehta, A. und Lin, A. Y. (1995): Generation of cytotoxic effector cells against human melanoma, Cancer Immunol Immunother 40) [6], Seite 397-409..

Levin, L. V. und Griffin, T. W. (1991): Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen, Cancer Lett 60) [2], Seite 143-52..

Lewko, W. M.; Hall, P. B. und Oldham, R. K. (2000): Growth of tumor-derived activated T cells for the treatment of advanced cancer, Cancer Biother Radiopharm 15) [4], Seite 357-66..

Li, J. und Baker, M. D. (2000): Mechanisms involved in targeted gene replacement in mammalian cells, Genetics 156) [2], Seite 809-21.

Li, Q. S.; Tanaka, S.; Kisenge, R. R.; Toyoda, H.; Azuma, E. und Komada, Y. (2000): Activation-induced T cell death occurs at G1A phase of the cell cycle, Eur J Immunol 30) [11], Seite 3329-37..

Li, R.; Xie, J.; Kantor, C.; Koistinen, V.; Altieri, D. C.; Nortamo, P. und Gahmberg, C. G. (1995): A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18, J Cell Biol 129) [4], Seite 1143-53..

Liberatore, C.; Capanni, M.; Albi, N.; Volpi, I.; Urbani, E.; Ruggeri, L.; Mencarelli, A.; Grignani, F. und Velardi, A. (1999): Natural killer cell-mediated lysis of autologous cells modified by gene therapy, J Exp Med 189) [12], Seite 1855-62..

Lin Chua, H. und Brahmi, Z. (2002): Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant, Cell Immunol 219) [1], Seite 57-70.

Lipshy, K. A.; Kostuchenko, P. J.; Hamad, G. G.; Bland, C. E.; Barrett, S. K. und Bear, H. D. (1997): Sensitizing T-lymphocytes for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanoma, Ann Surg Oncol 4) [4], Seite 334-41.

Lister, J.; Rybka, W. B.; Donnenberg, A. D.; deMagalhaes Silverman, M.; Pincus, S. M.; Bloom, E. J.; Elder, E. M.; Ball, E. D. und Whiteside, T. L. (1995): Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period, Clin Cancer Res 1) [6], Seite 607-14.

Liu, J. H.; Wei, S.; Blanchard, D. K. und Djeu, J. Y. (1994): Restoration of lytic function in a human natural killer cell line by gene transfection, Cell Immunol 156) [1], Seite 24-35.

Ljunggren, H. G. und Karre, K. (1990): In search of the 'missing self': MHC molecules and NK cell recognition, Immunol Today 11) [7], Seite 237-44.

Llano, M.; Lee, N.; Navarro, F.; Garcia, P.; Albar, J. P.; Geraghty, D. E. und Lopez-Botet, M. (1998): HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer, Eur J Immunol 28) [9], Seite 2854-63..

Lodish, H. F. (1991): Recognition of complex oligosaccharides by the multi-subunit asialoglycoprotein receptor, Trends Biochem Sci 16) [10], Seite 374-7.

Lopez Botet, M.; Bellon, T.; Llano, M.; Navarro, F.; Garcia, P. und de Miguel, M. (2000): Paired inhibitory and triggering NK cell receptors for HLA class I molecules, Hum Immunol 61) [1], Seite 7-17.

Love, P. E.; Lee, J. und Shores, E. W. (2000): Critical relationship between TCR signaling potential and TCR affinity during thymocyte selection, J Immunol 165) [6], Seite 3080-7..

Love, P. E. und Shores, E. W. (2000): ITAM multiplicity and thymocyte selection: how low can you go?, Immunity 12) [6], Seite 591-7..

Lowdell, M. W.; Craston, R.; Samuel, D.; Wood, M. E.; O'Neill, E.; Saha, V. und Prentice, H. G. (2002): Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells, Br J Haematol 117) [4], Seite 821-7..

Lowdell, M. W.; Shamim, F.; Hamon, M.; Macdonald, I. D. und Prentice, H. G. (1995): VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation, Exp Hematol 23) [14], Seite 1530-4..

Luo, D.; Vermijlen, D.; Vanderkerken, K.; Kuppen, P. J.; Seynaeve, C.; Eddouks, M.; Baekeland, M. und Wisse, E. (1999): Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells, J Hepatol 31) [1], Seite 110-6..

MacCallum, R. M.; Martin, A. C. und Thornton, J. M. (1996): Antibody-antigen interactions: contact analysis and binding site topography, J Mol Biol 262) [5], Seite 732-45.

Maenpaa, A.; Jaaskelainen, J.; Carpen, O.; Patarroyo, M. und Timonen, T. (1993): Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures, Int J Cancer 53) [5], Seite 850-5..

Maki, G.; Klingemann, H. G.; Martinson, J. A. und Tam, Y. K. (2001): Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92, J Hematother Stem Cell Res 10) [3], Seite 369-83.

Maki, G.; Tam, Y. K.; Berkahn, L. und Klingemann, H. G. (2003): Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia, Bone Marrow Transplant 31) [12], Seite 1119-25.

Malnati, M. S.; Peruzzi, M.; Parker, K. C.; Biddison, W. E.; Ciccone, E.; Moretta, A. und Long, E. O. (1995): Peptide specificity in the recognition of MHC class I by natural killer cell clones, Science 267) [5200], Seite 1016-8.

Malone, C. C.; Schiltz, P. M.; Mackintosh, A. D.; Beutel, L. D.; Heinemann, F. S. und Dillman, R. O. (2001): Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer, Cancer Biother Radiopharm 16) [5], Seite 381-90..

Marks, J. D.; Griffiths, A. D.; Malmqvist, M.; Clackson, T. P.; Bye, J. M. und Winter, G. (1992): By-passing immunization: building high affinity human antibodies by chain shuffling, Biotechnology 10) [7], Seite 779-83..

Martineau, P.; Jones, P. und Winter, G. (1998): Expression of an antibody fragment at high levels in the bacterial cytoplasm, J Mol Biol 280) [1], Seite 117-27..

Martin-Fontecha, A.; Assarsson, E.; Carbone, E.; Karre, K. und Ljunggren, H. G. (1999): Triggering of murine NK cells by CD40 and CD86 (B7-2), J Immunol 162) [10], Seite 5910-6.

Matsuda, M.; Salazar, F.; Petersson, M.; Masucci, G.; Hansson, J.; Pisa, P.; Zhang, Q. J.; Masucci, M. G. und Kiessling, R. (1994): Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression, J Exp Med 180) [6], Seite 2371-6..

Matsuoka, Y.; Matsuo, Y.; Okamoto, N.; Kuroki, M. und Ikehara, Y. (1991): Highly effective extraction of carcinoembryonic antigen with phosphatidylinositol-specific phospholipase C, Tumour Biol 12) [2], Seite 91-8.

Matthews, D. C. (1998): Immunotherapy in acute myelogenous leukemia and myelodysplastic syndrome, Leukemia 12 Suppl 1), Seite S33-6.

Matthey, B.; Engert, A.; Klimka, A.; Diehl, V. und Barth, S. (1999): A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins, Gene 229) [1-2], Seite 145-53..

Mattis, A. E.; Bernhardt, G.; Lipp, M. und Forster, R. (1997): Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay, J Immunol Methods 204) [2], Seite 135-42.

McGuinness, R. P.; Ge, Y.; Patel, S. D.; Kashmiri, S. V.; Lee, H. S.; Hand, P. H.; Schlom, J.; Finer, M. H. und McArthur, J. G. (1999): Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor, Hum Gene Ther 10) [2], Seite 165-73.

McKnight, R. A.; Wall, R. J. und Hennighausen, L. (1995): Expression of genomic and cDNA transgenes after co-integration in transgenic mice, Transgenic Res 4) [1], Seite 39-43.

McLaughlin, F.; Hayes, B. P.; Horgan, C. M.; Beesley, J. E.; Campbell, C. J. und Randi, A. M. (1998): Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta down- regulate intercellular adhesion molecule (ICAM)-2 expression on the endothelium, Cell Adhes Commun 6) [5], Seite 381-400.

Mellado, M.; Rodriguez-Frade, J. M.; Manes, S. und Martinez, A. C. (2001): Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation, Annu Rev Immunol 19), Seite 397-421.

Mesnil, M. und Yamasaki, H. (2000): Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication, Cancer Res 60) [15], Seite 3989-99.

Milenic, D. E.; Brady, E. D. und Brechbiel, M. W. (2004): Antibody-targeted radiation cancer therapy, Nat Rev Drug Discov 3) [6], Seite 488-99.

Miltenyi, S.; Muller, W.; Weichel, W. und Radbruch, A. (1990): High gradient magnetic cell separation with MACS, Cytometry 11) [2], Seite 231-8.

Mingari, M. C.; Vitale, C.; Romagnani, C.; Falco, M. und Moretta, L. (2001): p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells, Immunol Rev 181), Seite 260-8..

Mizoguchi, H.; O'Shea, J. J.; Longo, D. L.; Loeffler, C. M.; McVicar, D. W. und Ochoa, A. C. (1992): Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice, Science 258) [5089], Seite 1795-8..

Mizuno, S.; Emi, N.; Kasai, M.; Ishitani, A. und Saito, H. (2000): Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia, Br J Haematol 111) [1], Seite 280-2..

Moertel, C. G.; O'Fallon, J. R.; Go, V. L.; O'Connell, M. J. und Thynne, G. S. (1986): The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer, Cancer 58) [3], Seite 603-10..

Molife, R. und Hancock, B. W. (2002): Adjuvant therapy of malignant melanoma, Crit Rev Oncol Hematol 44) [1], Seite 81-102.

Montel, A. H.; Bochan, M. R.; Goebel, W. S. und Brahmi, Z. (1995): Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line, Cell Immunol 165) [2], Seite 312-7.

Montel, A. H.; Morse, P. A. und Brahmi, Z. (1995): Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line, Cell Immunol 160) [1], Seite 104-14.

Moretta, A.; Biassoni, R.; Bottino, C.; Mingari, M. C. und Moretta, L. (2000): Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis, Immunol Today 21) [5], Seite 228-34.

Moretta, A.; Bottino, C.; Vitale, M.; Pende, D.; Cantoni, C.; Mingari, M. C.; Biassoni, R. und Moretta, L. (2001): Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis, Annu Rev Immunol 19), Seite 197-223.

Moretta, A.; Sivori, S.; Vitale, M.; Pende, D.; Morelli, L.; Augugliaro, R.; Bottino, C. und Moretta, L. (1995): Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells, J Exp Med 182) [3], Seite 875-84.

Moretta, L.; Biassoni, R.; Bottino, C.; Mingari, M. C. und Moretta, A. (2000): Human NK-cell receptors, Immunol Today 21) [9], Seite 420-2.

Moretta, L.; Ferlazzo, G.; Mingari, M. C.; Melioli, G. und Moretta, A. (2003): Human natural killer cell function and their interactions with dendritic cells, Vaccine 21 Suppl 2), Seite S38-42.

Moritz, D. und Groner, B. (1995): A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity, Gene Ther 2) [8], Seite 539-46.

Moritz, D.; Wels, W.; Mattern, J. und Groner, B. (1994): Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells, Proc Natl Acad Sci U S A 91) [10], Seite 4318-22.

Mucke, S.; Polack, A.; Pawlita, M.; Zehnpfennig, D.; Massoudi, N.; Bohlen, H.; Doerfler, W.; Bornkamm, G.; Diehl, V. und Wolf, J. (1997): Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells, Gene Ther 4) [2], Seite 82-92.

Murakami, M.; Kuroki, M.; Arakawa, F.; Haruno, M.; Kuwahara, M.; Ozaki, H.; Senba, T. und Matsuoka, Y. (1996): Binding reactivity of monoclonal anti-carcinoembryonic antigen (CEA) antibodies with cell membrane-bound CEA and with free CEA in solution, Immunol Invest 25) [1-2], Seite 23-35.

Murakami, M.; Kuroki, M.; Arakawa, F.; Kuwahara, M.; Oikawa, S.; Nakazato, H. und Matsuoka, Y. (1995): A reference of the GOLD classification of monoclonal antibodies against carcinoembryonic antigen to the domain structure of the carcinoembryonic antigen molecule, Hybridoma 14) [1], Seite 19-28..

Murphy, J.B. (1926): Monography, Rockefeller Institute of Medicine Research 21), Seite 1-168 .

Myking, A. (1969): Immunosuppression and cancer, Lancet 1) [7597], Seite 731..

Nagashima, S.; Mailliard, R.; Kashii, Y.; Reichert, T. E.; Herberman, R. B.; Robbins, P. und Whiteside, T. L. (1998): Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo, Blood 91) [10], Seite 3850-61.

Nagel, G.; Grunert, F.; Kuijpers, T. W.; Watt, S. M.; Thompson, J. und Zimmermann, W. (1993): Genomic organization, splice variants and expression of CGM1, a CD66- related member of the carcinoembryonic antigen gene family, Eur J Biochem 214) [1], Seite 27-35..

Nakagoe, T.; Sawai, T.; Tsuji, T.; Jibiki, M. A.; Nanashima, A.; Yamaguchi, H.; Yasutake, T.; Kurosaki, N.; Ayabe, H. und Arisawa, K. (2001): Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer, Cancer Detect Prev 25) [3], Seite 299-308.

Natarajan, K.; Dimasi, N.; Wang, J.; Mariuzza, R. A. und Margulies, D. H. (2002): Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination, Annu Rev Immunol 20), Seite 853-85.

Naylor, C.; Gilham, D. und Hawkins, R. (2001): Optimisation of Retroviral Transduction and Survival of Human Natural Killer Cells: Implications for Gene Therapy, Molecular Therapy - The Forth Annual Meeting of the American Society of Gene Therapy (ASGT), Seattle, WA.

N'Cho, M.; Hobbs, J. A. und Brahmi, Z. (1999): Over-expression of multidrug resistance P-glycoprotein inhibits NK granule-mediated lytic ability without affecting the Fas lytic pathway, Hum Immunol 60) [3], Seite 223-30..

Nishihara, E.; Nagayama, Y.; Narimatsu, M.; Namba, H.; Watanabe, M.; Niwa, M. und Yamashita, S. (1998): Treatment of thyroid carcinoma cells with four different suicide gene/prodrug combinations in vitro, Anticancer Res 18) [3a], Seite 1521-5.

Nolan, K. F.; Yun, C. O.; Akamatsu, Y.; Murphy, J. C.; Leung, S. O.; Beecham, E. J. und Junghans, R. P. (1999): Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA, Clin Cancer Res 5) [12], Seite 3928-41..

North, R. J. (1982): Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells, J Exp Med 155) [4], Seite 1063-74..

Oberyszyn, T. M.; Conti, C. J.; Ross, M. S.; Oberyszyn, A. S.; Tober, K. L.; Rackoff, A. I. und Robertson, F. M. (1998): Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion, Carcinogenesis 19) [3], Seite 445-55..

Okayama, H. und Berg, P. (1982): High-efficiency cloning of full-length cDNA, Mol Cell Biol 2) [2], Seite 161-70.

Ortaldo, J. R.; Mason, A. T. und O'Shea, J. J. (1995): Receptor-induced death in human natural killer cells: involvement of CD16, J Exp Med 181) [1], Seite 339-44..

Overwijk, W. W.; Lee, D. S.; Surman, D. R.; Irvine, K. R.; Touloukian, C. E.; Chan, C. C.; Carroll, M. W.; Moss, B.; Rosenberg, S. A. und Restifo, N. P. (1999): Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes, Proc Natl Acad Sci U S A 96) [6], Seite 2982-7..

Owens, R. J. und Young, R. J. (1994): The genetic engineering of monoclonal antibodies, J Immunol Methods 168) [2], Seite 149-65.

Parajuli, P.; Nishioka, Y.; Nishimura, N.; Singh, S. M.; Hanibuchi, M.; Nokihara, H.; Yanagawa, H. und Sone, S. (1999): Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing, J Leukoc Biol 65) [6], Seite 764-70..

Pardoll, D. (2003): Does the immune system see tumors as foreign or self?, Annu Rev Immunol 21), Seite 807-39.

Patel, S. D.; Moskalenko, M.; Smith, D.; Maske, B.; Finer, M. H. und McArthur, J. G. (1999): Impact of chimeric immune receptor extracellular protein domains on T cell function, Gene Ther 6) [3], Seite 412-9.

Patel, S. D.; Moskalenko, M.; Tian, T.; Smith, D.; McGuinness, R.; Chen, L.; Winslow, G. A.; Kashmiri, S.; Schlom, J.; Stanners, C. P.; Finer, M. H. und McArthur, J. G. (2000): T-cell killing of heterogenous tumor or viral targets with bispecific chimeric immune receptors, Cancer Gene Ther 7) [8], Seite 1127-34.

Paul, P.; Rouas-Freiss, N.; Khalil-Daher, I.; Moreau, P.; Riteau, B.; Le Gal, F. A.; Avril, M. F.; Dausset, J.; Guillet, J. G. und Carosella, E. D. (1998): HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance, Proc Natl Acad Sci U S A 95) [8], Seite 4510-5.

Payne, A. S. und Cornelius, L. A. (2002): The role of chemokines in melanoma tumor growth and metastasis, J Invest Dermatol 118) [6], Seite 915-22..

Penn, I. (2000): Post-transplant malignancy: the role of immunosuppression, Drug Saf 23) [2], Seite 101-13..

Persic, L.; Righi, M.; Roberts, A.; Hoogenboom, H. R.; Cattaneo, A. und Bradbury, A. (1997): Targeting vectors for intracellular immunisation, Gene 187) [1], Seite 1-8.

Philben, V. J.; Jakowatz, J. G.; Beatty, B. G.; Vlahos, W. G.; Paxton, R. J.; Williams, L. E.; Shively, J. E. und Beatty, J. D. (1986): The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody, Cancer 57) [3], Seite 571-6..

Pluckthun, A. (1991): Antibody engineering: advances from the use of Escherichia coli expression systems, Biotechnology (N Y) 9) [6], Seite 545-51.

Polakova, K. und Russ, G. (2000): Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted, Neoplasma 47) [6], Seite 342-8.

Potter, K. N.; Li, Y. und Capra, J. D. (1993): Antibody production in the baculovirus expression system, Int Rev Immunol 10) [2-3], Seite 103-12.

Power, C. A. (2003): Knock out models to dissect chemokine receptor function in vivo, J Immunol Methods 273) [1-2], Seite 73-82.

Prado, I. B.; Laudanna, A. A. und Carneiro, C. R. (1995): Susceptibility of colorectal-carcinoma cells to natural-killer-mediated lysis: relationship to CEA expression and degree of differentiation, Int J Cancer 61) [6], Seite 854-60..

Pross, H. F. und Lotzova, E. (1993): Role of natural killer cells in cancer, Nat Immun 12) [4-5], Seite 279-92.

Rabinowich, H.; Reichert, T. E.; Kashii, Y.; Gastman, B. R.; Bell, M. C. und Whiteside, T. L. (1998): Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes, J Clin Invest 101) [11], Seite 2579-88..

Rabinowich, H.; Suminami, Y.; Reichert, T. E.; Crowley-Nowick, P.; Bell, M.; Edwards, R. und Whiteside, T. L. (1996): Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma, Int J Cancer 68) [3], Seite 276-84..

Ramm, K. und Pluckthun, A. (2000): The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA. II. Isomerase-independent chaperone activity in vitro, J Biol Chem 275) [22], Seite 17106-13.

Ran, S.; Gao, B.; Duffy, S.; Watkins, L.; Rote, N. und Thorpe, P. E. (1998): Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature, Cancer Res 58) [20], Seite 4646-53..

Raulet, D. H. und Held, W. (1995): Natural killer cell receptors: the offs and ons of NK cell recognition, Cell 82) [5], Seite 697-700.

Reese, M. R. und Chow, D. A. (1992): Tumor progression in vivo: increased soybean agglutinin lectin binding, N-acetylgalactosamine-specific lectin expression, and liver metastasis potential, Cancer Res 52) [19], Seite 5235-43.

Reichert, T. E.; Rabinowich, H.; Johnson, J. T. und Whiteside, T. L. (1998): Mechanisms responsible for signaling and functional defects, J Immunother 21) [4], Seite 295-306..

Reinhold, U.; Liu, L.; Ludtke Handjery, H. C.; Heuser, C.; Hombach, A.; Wang, X.; Tilgen, W.; Ferrone, S. und Abken, H. (1999): Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor, J Invest Dermatol 112) [5], Seite 744-50.

Ren Heidenreich, L.; Hayman, G. T. und Trevor, K. T. (2000): Specific targeting of EGP-2+ tumor cells by primary lymphocytes modified with chimeric T cell receptors, Hum Gene Ther 11) [1], Seite 9-19.

Ren-Heidenreich, L.; Mordini, R.; Hayman, G. T.; Siebenlist, R. und LeFever, A. (2002): Comparison of the TCR zeta-chain with the FcR gamma-chain in chimeric TCR constructs for T cell activation and apoptosis, Cancer Immunol Immunother 51) [8], Seite 417-23.

Renkvist, N.; Castelli, C.; Robbins, P. F. und Parmiani, G. (2001): A listing of human tumor antigens recognized by T cells, Cancer Immunol Immunother 50) [1], Seite 3-15..

Renner, C.; Kubuschok, B.; Trumper, L. und Pfreundschuh, M. (2001): Clinical approaches to vaccination in oncology, Ann Hematol 80) [5], Seite 255-66.

Rickles, F. R.; Shoji, M. und Abe, K. (2001): The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer, Int J Hematol 73) [2], Seite 145-50..

Riddell, S. R.; Elliott, M.; Lewinsohn, D. A.; Gilbert, M. J.; Wilson, L.; Manley, S. A.; Lupton, S. D.; Overell, R. W.; Reynolds, T. C.; Corey, L. und Greenberg, P. D. (1996): T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients, Nat Med 2) [2], Seite 216-23.

Rivoltini, L.; Cattoretti, G.; Arienti, F.; Mastroianni, A. und Parmiani, G. (1992): CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes, Int J Biol Markers 7) [3], Seite 143-7..

Roberts, M. R.; Cooke, K. S.; Tran, A. C.; Smith, K. A.; Lin, W. Y.; Wang, M.; Dull, T. J.; Farson, D.; Zsebo, K. M. und Finer, M. H. (1998): Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains, J Immunol 161) [1], Seite 375-84.

Roberts, M. R.; Qin, L.; Zhang, D.; Smith, D. H.; Tran, A. C.; Dull, T. J.; Groopman, J. E.; Capon, D. J.; Byrn, R. A. und Finer, M. H. (1994): Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors, Blood 84) [9], Seite 2878-89.

Roessig, C.; Scherer, S. P.; Baer, A.; Vormoor, J.; Rooney, C. M.; Brenner, M. K. und Juergens, H. (2002): Targeting CD19 with genetically modified EBV-specific human T lymphocytes, Ann Hematol 81 Suppl 2), Seite S42-3.

Romeo, C.; Amiot, M. und Seed, B. (1992): Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain, Cell 68) [5], Seite 889-97.

Roncarolo, M. G.; Bigler, M.; Haanen, J. B.; Yssel, H.; Bacchetta, R.; de Vries, J. E. und Spits, H. (1991): Natural killer cell clones can efficiently process and present protein antigens, J Immunol 147) [3], Seite 781-7.

Rooney, C. M.; Smith, C. A.; Ng, C. Y.; Loftin, S. K.; Sixbey, J. W.; Gan, Y.; Srivastava, D. K.; Bowman, L. C.; Krance, R. A.; Brenner, M. K. und Heslop, H. E. (1998): Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients, Blood 92) [5], Seite 1549-55.

Rooney, C. M.; Smith, C. A.; Ng, C. Y.; Loftin, S.; Li, C.; Krance, R. A.; Brenner, M. K. und Heslop, H. E. (1995): Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation, Lancet 345) [8941], Seite 9-13.

Rosenberg, S. A. (1991): Immunotherapy and gene therapy of cancer, Cancer Res 51) [18 Suppl], Seite 5074-5079.

Rosenberg, S. A.; Aebersold, P.; Cornetta, K.; Kasid, A.; Morgan, R. A.; Moen, R.; Karson, E. M.; Lotze, M. T.; Yang, J. C.; Topalian, S. L. und et al. (1990): Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction, N Engl J Med 323) [9], Seite 570-8..

Rosenberg, S. A.; Yannelli, J. R.; Yang, J. C.; Topalian, S. L.; Schwartzentruber, D. J.; Weber, J. S.; Parkinson, D. R.; Seipp, C. A.; Einhorn, J. H. und White, D. E. (1994): Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2, J Natl Cancer Inst 86) [15], Seite 1159-66.

Rosenstein, M.; Eberlein, T. J. und Rosenberg, S. A. (1984): Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations, J Immunol 132) [4], Seite 2117-22..

Rossig, C.; Bollard, C. M.; Nuchtern, J. G.; Rooney, C. M. und Brenner, M. K. (2002): Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy, Blood 99) [6], Seite 2009-16.

Rott, L. S.; Briskin, M. J.; Andrew, D. P.; Berg, E. L. und Butcher, E. C. (1996): A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation, J Immunol 156) [10], Seite 3727-36.

Rouas Freiss, N.; Marchal, R. E.; Kirszenbaum, M.; Dausset, J. und Carosella, E. D. (1997): The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?, Proc Natl Acad Sci U S A 94) [10], Seite 5249-54.

Ruggeri, L.; Capanni, M.; Martelli, M. F. und Velardi, A. (2001): Cellular therapy: exploiting NK cell alloreactivity in transplantation, Curr Opin Hematol 8) [6], Seite 355-9.

Ruggeri, L.; Capanni, M.; Urbani, E.; Perruccio, K.; Shlomchik, W. D.; Tosti, A.; Posati, S.; Rogaia, D.; Frassoni, F.; Aversa, F.; Martelli, M. F. und Velardi, A. (2002): Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants, Science 295) [5562], Seite 2097-100.

Ryabova, L. A.; Desplancq, D.; Spirin, A. S. und Pluckthun, A. (1997): Functional antibody production using cell-free translation: effects of protein disulfide isomerase and chaperones, Nat Biotechnol 15) [1], Seite 79-84.

Sahin, U.; Tureci, O. und Pfreundschuh, M. (1997): Serological identification of human tumor antigens, Curr Opin Immunol 9) [5], Seite 709-16..

Salazar-Onfray, F.; Charo, J.; Petersson, M.; Freland, S.; Noffz, G.; Qin, Z.; Blankenstein, T.; Ljunggren, H. G. und Kiessling, R. (1997): Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10, J Immunol 159) [7], Seite 3195-202..

Sanchez, L.; Ayala, M.; Freyre, F.; Pedroso, I.; Bell, H.; Falcon, V. und Gavilondo, J. V. (1999): High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen, J Biotechnol 72) [1-2], Seite 13-20..

Sawyer, J. R.; Schlom, J. und Kashmiri, S. V. (1994): The effects of induction conditions on production of a soluble anti-tumor sFv in Escherichia coli, Protein Eng 7) [11], Seite 1401-6.

Scanlan, M. J.; Chen, Y. T.; Williamson, B.; Gure, A. O.; Stockert, E.; Gordan, J. D.; Tureci, O.; Sahin, U.; Pfreundschuh, M. und Old, L. J. (1998): Characterization of human colon cancer antigens recognized by autologous antibodies, Int J Cancer 76) [5], Seite 652-8..

Schirrmann, T. und Pecher, G. (2001): Tumor-specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transfer, Cancer Immunol Immunother 50) [10], Seite 549-56..

Schmiedl, A.; Breitling, F.; Winter, C. H.; Queitsch, I. und Dubel, S. (2000): Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli, J Immunol Methods 242) [1-2], Seite 101-14..

Schubeler, D.; Lorincz, M. C.; Cimbora, D. M.; Telling, A.; Feng, Y. Q.; Bouhassira, E. E. und Groudine, M. (2000): Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation, Mol Cell Biol 20) [24], Seite 9103-12..

Schwartz, M. A.; Lovett, D. R.; Redner, A.; Finn, R. D.; Graham, M. C.; Divgi, C. R.; Dantis, L.; Gee, T. S.; Andreeff, M.; Old, L. J. und et al. (1993): Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias, J Clin Oncol 11) [2], Seite 294-303.

Seliger, B.; Maeurer, M. J. und Ferrone, S. (1997): TAP off--tumors on, Immunol Today 18) [6], Seite 292-9..

Selvakumar, A.; Steffens, U. und Dupont, B. (1996): NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains, Tissue Antigens 48) [4 Pt 1], Seite 285-94..

Shaheen, R. M.; Davis, D. W.; Liu, W.; Zebrowski, B. K.; Wilson, M. R.; Bucana, C. D.; McConkey, D. J.; McMahon, G. und Ellis, L. M. (1999): Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis, Cancer Res 59) [21], Seite 5412-6..

Sharon, J. und Givol, D. (1976): Preparation of Fv fragment from the mouse myeloma XRPC-25 immunoglobulin possessing anti-dinitrophenyl activity, Biochemistry 15) [7], Seite 1591-4.

Shawler, D. L.; Bartholomew, R. M.; Garrett, M. A.; Trauger, R. J.; Dorigo, O.; Beveren, C. V.; Marchese, A.; Ferre, F.; Duffy, C.; Carlo, D. J.; Sherman, L. A.; Gold, D. P. und Sobol, R. E. (2002): Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine, Clin Exp Immunol 129) [1], Seite 99-106..

Shibuya, A.; Campbell, D.; Hannum, C.; Yssel, H.; Franz-Bacon, K.; McClanahan, T.; Kitamura, T.; Nicholl, J.; Sutherland, G. R.; Lanier, L. L. und Phillips, J. H. (1996): DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes, Immunity 4) [6], Seite 573-81.

Shibuya, A.; Lanier, L. L. und Phillips, J. H. (1998): Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor, J Immunol 161) [4], Seite 1671-6.

Shibuya, K.; Lanier, L. L.; Phillips, J. H.; Ochs, H. D.; Shimizu, K.; Nakayama, E.; Nakauchi, H. und Shibuya, A. (1999): Physical and functional association of LFA-1 with DNAM-1 adhesion molecule, Immunity 11) [5], Seite 615-23.

Shigeoka, H.; Karsten, U.; Okuno, K. und Yasutomi, M. (1999): Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody, Tumour Biol 20) [3], Seite 139-46.

Shiraki, K.; Tsuji, N.; Shioda, T.; Isselbacher, K. J. und Takahashi, H. (1997): Expression of Fas ligand in liver metastases of human colonic adenocarcinomas, Proc Natl Acad Sci U S A 94) [12], Seite 6420-5..

Shores, E.; Flamand, V.; Tran, T.; Grinberg, A.; Kinet, J. P. und Love, P. E. (1997): Fc epsilonRI gamma can support T cell development and function in mice lacking endogenous TCR zeta-chain, J Immunol 159) [1], Seite 222-30..

Silverman, D. H.; Delpassand, E. S.; Torabi, F.; Goy, A.; McLaughlin, P. und Murray, J. L. (2004): Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues, Cancer Treat Rev 30) [2], Seite 165-72.

Skerra, A. und Pluckthun, A. (1988): Assembly of a functional immunoglobulin Fv fragment in Escherichia coli, Science 240) [4855], Seite 1038-41.

Smyth, M. J. (1995): Dual mechanisms of lymphocyte-mediated cytotoxicity serve to control and deliver the immune response, Bioessays 17) [10], Seite 891-8.

Sorachi, K.; Sugie, K.; Maekawa, N.; Takami, M.; Kawabe, T.; Kumagai, S.; Imura, H. und Yodoi, J. (1992): Induction and function of Fc epsilon RII on YT cells; possible role of ADF/thioredoxin in Fc epsilon RII expression, Immunobiology 185) [2-4], Seite 193-206 Mitte : Chirurgie : 156 (1979/80) - 199 (1998) Wedding : Med. Bibliothek : 156 (1979/80) -.

Stancovski, I.; Schindler, D. G.; Waks, T.; Yarden, Y.; Sela, M. und Eshhar, Z. (1993): Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors, J Immunol 151) [11], Seite 6577-82.

Stanislawski, T.; Voss, R. H.; Lotz, C.; Sadovnikova, E.; Willemsen, R. A.; Kuball, J.; Ruppert, T.; Bolhuis, R. L.; Melief, C. J.; Huber, C.; Stauss, H. J. und Theobald, M. (2001): Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer, Nat Immunol 2) [10], Seite 962-70..

Stauss, H. J. (1999): Immunotherapy with CTLs restricted by nonself MHC, Immunol Today 20) [4], Seite 180-3. 00001443 00001443.

Su, B.; Bochan, M. R.; Hanna, W. L.; Froelich, C. J. und Brahmi, Z. (1994): Human granzyme B is essential for DNA fragmentation of susceptible target cells, Eur J Immunol 24) [9], Seite 2073-80..

Szydlo, R.; Goldman, J. M.; Klein, J. P.; Gale, R. P.; Ash, R. C.; Bach, F. H.; Bradley, B. A.; Casper, J. T.; Flomenberg, N.; Gajewski, J. L.; Gluckman, E.; Henslee-Downey, P. J.; Hows, J. M.; Jacobsen, N.; Kolb, H. J.; Lowenberg, B.; Masaoka, T.; Rowlings, P. A.; Sondel, P. M.; van Bekkum, D. W.; van Rood, J. J.; Vowels, M. R.; Zhang, M. J. und Horowitz, M. M. (1997): Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings, J Clin Oncol 15) [5], Seite 1767-77..

Tachibana, M.; Takemoto, Y.; Nakashima, Y.; Kinugasa, S.; Kotoh, T.; Dhar, D. K.; Kohno, H. und Nagasue, N. (1998): Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer, J Am Coll Surg 187) [1], Seite 64-8..

Takami, N.; Misumi, Y.; Kuroki, M.; Matsuoka, Y. und Ikehara, Y. (1988): Evidence for carboxyl-terminal processing and glycolipid-anchoring of human carcinoembryonic antigen, J Biol Chem 263) [25], Seite 12716-20..

Takamori, H.; Oades, Z. G.; Hoch, O. C.; Burger, M. und Schraufstatter, I. U. (2000): Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1, Pancreas 21) [1], Seite 52-6..

Tam, Y. K.; Maki, G.; Miyagawa, B.; Hennemann, B.; Tonn, T. und Klingemann, H. G. (1999): Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy, Hum Gene Ther 10) [8], Seite 1359-73.

Tam, Y. K.; Martinson, J. A.; Doligosa, K. und Klingemann, H. G. (2003): Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy, Cytotherapy 5) [3], Seite 259-72.

Taub, D. D.; Sayers, T. J.; Carter, C. R. und Ortaldo, J. R. (1995): Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis, J Immunol 155) [8], Seite 3877-88.

Tavladoraki, P.; Girotti, A.; Donini, M.; Arias, F. J.; Mancini, C.; Morea, V.; Chiaraluce, R.; Consalvi, V. und Benvenuto, E. (1999): A single-chain antibody fragment is functionally expressed in the cytoplasm of both Escherichia coli and transgenic plants, Eur J Biochem 262) [2], Seite 617-24..

Teng, J. M.; Liu, X. R.; Mills, G. B. und Dupont, B. (1996): CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C, J Immunol 156) [9], Seite 3222-32.

Thompson, J. A.; Eades-Perner, A. M.; Ditter, M.; Muller, W. J. und Zimmermann, W. (1997): Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy, Int J Cancer 72) [1], Seite 197-202..

Thompson, J.; Epting, T.; Schwarzkopf, G.; Singhofen, A.; Eades-Perner, A. M.; van Der Putten, H. und Zimmermann, W. (2000): A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy, Int J Cancer 86) [6], Seite 863-9..

Thomson, D. M.; Krupey, J.; Freedman, S. O. und Gold, P. (1969): The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system, Proc Natl Acad Sci U S A 64) [1], Seite 161-7.

Timonen, T.; Gahmberg, C. G. und Patarroyo, M. (1990): Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes, Int J Cancer 46) [6], Seite 1035-40..

Tonn, T.; Becker, S.; Esser, R.; Schwabe, D. und Seifried, E. (2001): Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92, J Hematother Stem Cell Res 10) [4], Seite 535-44.

Topalian, S. L.; Solomon, D. und Rosenberg, S. A. (1989): Tumor-specific cytolysis by lymphocytes infiltrating human melanomas, J Immunol 142) [10], Seite 3714-25..

Tran, A. C.; Zhang, D.; Byrn, R. und Roberts, M. R. (1995): Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes, J Immunol 155) [2], Seite 1000-9.

Trotta, R.; Puorro, K. A.; Paroli, M.; Azzoni, L.; Abebe, B.; Eisenlohr, L. C. und Perussia, B. (1998): Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal- regulated kinases, J Immunol 161) [12], Seite 6648-56..

Tsumoto, K.; Nakaoki, Y.; Ueda, Y.; Ogasahara, K.; Yutani, K.; Watanabe, K. und Kumagai, I. (1994): Effect of the order of antibody variable regions on the expression of the single-chain HyHEL10 Fv fragment in E. coli and the thermodynamic analysis of its antigen-binding properties, Biochem Biophys Res Commun 201) [2], Seite 546-51.

Tureci, O.; Sahin, U.; Schobert, I.; Koslowski, M.; Scmitt, H.; Schild, H. J.; Stenner, F.; Seitz, G.; Rammensee, H. G. und Pfreundschuh, M. (1996): The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40, Cancer Res 56) [20], Seite 4766-72..

Tureci, O.; Sahin, U.; Zwick, C.; Neumann, F. und Pfreundschuh, M. (1999): Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens, Hybridoma 18) [1], Seite 23-8..

Uckert, W.; Willimsky, G.; Pedersen, F. S.; Blankenstein, T. und Pedersen, L. (1998): RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes, Hum Gene Ther 9) [17], Seite 2619-27.

Uharek, L.; Zeis, M.; Glass, B.; Steinmann, J.; Dreger, P.; Gassmann, W.; Schmitz, N. und Muller Ruchholtz, W. (1996): High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2, Leukemia 10) [11], Seite 1758-64.

Uherek, C.; Tonn, T.; Uherek, B.; Becker, S.; Schnierle, B.; Klingemann, H. G. und Wels, W. (2002): Retargeting of natural killer-cell cytolytic activity to ErbB2- expressing cancer cells results in efficient and selective tumor cell destruction, Blood 100) [4], Seite 1265-73..

Uzzo, R. G.; Rayman, P.; Kolenko, V.; Clark, P. E.; Bloom, T.; Ward, A. M.; Molto, L.; Tannenbaum, C.; Worford, L. J.; Bukowski, R.; Tubbs, R.; Hsi, E. D.; Bander, N. H.; Novick, A. C. und Finke, J. H. (1999): Mechanisms of apoptosis in T cells from patients with renal cell carcinoma, Clin Cancer Res 5) [5], Seite 1219-29..

van Oers, N. S.; Love, P. E.; Shores, E. W. und Weiss, A. (1998): Regulation of TCR signal transduction in murine thymocytes by multiple TCR zeta-chain signaling motifs, J Immunol 160) [1], Seite 163-70..

Vanhove, M.; Usherwood, Y. K. und Hendershot, L. M. (2001): Unassembled Ig heavy chains do not cycle from BiP in vivo but require light chains to trigger their release, Immunity 15) [1], Seite 105-14.

Visonneau, S.; Cesano, A.; Jeglum, K. A. und Santoli, D. (1999): Adoptive therapy of canine metastatic mammary carcinoma with the human MHC non-restricted cytotoxic T-cell line TALL-104, Oncol Rep 6) [6], Seite 1181-8..

Visonneau, S.; Cesano, A.; Porter, D. L.; Luger, S. L.; Schuchter, L.; Kamoun, M.; Torosian, M. H.; Duffy, K.; Sickles, C.; Stadtmauer, E. A. und Santoli, D. (2000): Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer, Clin Cancer Res 6) [5], Seite 1744-54.

Vitale, C.; Romagnani, C.; Falco, M.; Ponte, M.; Vitale, M.; Moretta, A.; Bacigalupo, A.; Moretta, L. und Mingari, M. C. (1999): Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells, Proc Natl Acad Sci U S A 96) [26], Seite 15091-6..

Vitale, C.; Romagnani, C.; Puccetti, A.; Olive, D.; Costello, R.; Chiossone, L.; Pitto, A.; Bacigalupo, A.; Moretta, L. und Mingari, M. C. (2001): Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells, Proc Natl Acad Sci U S A 98) [10], Seite 5764-9..

Vitale, M.; Falco, M.; Castriconi, R.; Parolini, S.; Zambello, R.; Semenzato, G.; Biassoni, R.; Bottino, C.; Moretta, L. und Moretta, A. (2001): Identification of NKp80, a novel triggering molecule expressed by human NK cells, Eur J Immunol 31) [1], Seite 233-42..

von Mehren, M.; Adams, G. P. und Weiner, L. M. (2003): Monoclonal antibody therapy for cancer, Annu Rev Med 54), Seite 343-69.

Vujanovic, N. L.; Yasumura, S.; Hirabayashi, H.; Lin, W. C.; Watkins, S.; Herberman, R. B. und Whiteside, T. L. (1995): Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues, J Immunol 154) [1], Seite 281-9.

Walker, P. R.; Calzascia, T.; Schnuriger, V.; Chalmers, D.; Saas, P. und Dietrich, P. Y. (2000): Loss of Fas (CD95/APO-1) expression by antigen-specific cytotoxic T cells is reversed by inhibiting DNA methylation, Cell Immunol 206) [1], Seite 51-8..

Walker, P. R.; Saas, P. und Dietrich, P. Y. (1997): Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back, J Immunol 158) [10], Seite 4521-4..

Walker, R. E.; Bechtel, C. M.; Natarajan, V.; Baseler, M.; Hege, K. M.; Metcalf, J. A.; Stevens, R.; Hazen, A.; Blaese, R. M.; Chen, C. C.; Leitman, S. F.; Palensky, J.; Wittes, J.; Davey, R. T., Jr.; Falloon, J.; Polis, M. A.; Kovacs, J. A.; Broad, D. F.; Levine, B. L.; Roberts, M. R.; Masur, H. und Lane, H. C. (2000): Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection, Blood 96) [2], Seite 467-74.

Wei, S.; Gamero, A. M.; Liu, J. H.; Daulton, A. A.; Valkov, N. I.; Trapani, J. A.; Larner, A. C.; Weber, M. J. und Djeu, J. Y. (1998): Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2, J Exp Med 187) [11], Seite 1753-65..

Weijtens, M. E.; Hart, E. H. und Bolhuis, R. L. (2000): Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production, Gene Ther 7) [1], Seite 35-42.

Weijtens, M. E.; Willemsen, R. A.; Hart, E. H. und Bolhuis, R. L. (1998): A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes, Gene Ther 5) [9], Seite 1195-203.

Weijtens, M. E.; Willemsen, R. A.; Valerio, D.; Stam, K. und Bolhuis, R. L. (1996): Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity, J Immunol 157) [2], Seite 836-43.

Weijtens, M. E.; Willemsen, R. A.; van Krimpen, B. A. und Bolhuis, R. L. (1998): Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules, Int J Cancer 77) [2], Seite 181-7.

Weinfeld, M.; Xing, J. Z.; Lee, J.; Leadon, S. A.; Cooper, P. K. und Le, X. C. (2001): Factors influencing the removal of thymine glycol from DNA in gamma-irradiated human cells, Prog Nucleic Acid Res Mol Biol 68), Seite 139-49.

Weissman, A. M.; Baniyash, M.; Hou, D.; Samelson, L. E.; Burgess, W. H. und Klausner, R. D. (1988): Molecular cloning of the zeta chain of the T cell antigen receptor, Science 239) [4843], Seite 1018-21.

Whiteside, T. L. (1999): Signaling defects in T lymphocytes of patients with malignancy, Cancer Immunol Immunother 48) [7], Seite 346-52.

Whitlow, M.; Bell, B. A.; Feng, S. L.; Filpula, D.; Hardman, K. D.; Hubert, S. L.; Rollence, M. L.; Wood, J. F.; Schott, M. E.; Milenic, D. E. und et al. (1993): An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability, Protein Eng 6) [8], Seite 989-95.

Wiedle, G.; Johnson-Leger, C. und Imhof, B. A. (1999): A chimeric cell adhesion molecule mediates homing of lymphocytes to vascularized tumors, Cancer Res 59) [20], Seite 5255-63.

Willemsen, R. A.; Debets, R.; Hart, E.; Hoogenboom, H. R.; Bolhuis, R. L. und Chames, P. (2001): A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes, Gene Ther 8) [21], Seite 1601-8.

Willemsen, R. A.; Weijtens, M. E.; Ronteltap, C.; Eshhar, Z.; Gratama, J. W.; Chames, P. und Bolhuis, R. L. (2000): Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR, Gene Ther 7) [16], Seite 1369-77.

Williams, D. A. und Baum, C. (2003): Medicine. Gene therapy--new challenges ahead, Science 302) [5644], Seite 400-1.

Wilson, J. L.; Charo, J.; Martin-Fontecha, A.; Dellabona, P.; Casorati, G.; Chambers, B. J.; Kiessling, R.; Bejarano, M. T. und Ljunggren, H. G. (1999): NK cell triggering by the human costimulatory molecules CD80 and CD86, J Immunol 163) [8], Seite 4207-12.

Wu, A. M.; Chen, W.; Raubitschek, A.; Williams, L. E.; Neumaier, M.; Fischer, R.; Hu, S. Z.; Odom Maryon, T.; Wong, J. Y. und Shively, J. E. (1996): Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers, Immunotechnology 2) [1], Seite 21-36.

Wu, T. T. und Kabat, E. A. (1970): An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity, J Exp Med 132) [2], Seite 211-50.

Xu, J. L. und Davis, M. M. (2000): Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities, Immunity 13) [1], Seite 37-45..

Yamabe, T.; Takakura, K.; Sugie, K.; Kitaoka, Y.; Takeda, S.; Okubo, Y.; Teshigawara, K.; Yodoi, J. und Hori, T. (1997): Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15, Immunology 91) [1], Seite 151-8..

Yan, X. W.; Wong, J. Y.; Esteban, J. M.; Kuhn, J. A.; Beatty, B. G.; Beatty, J. D. und Shively, J. E. (1992): Effects of recombinant human gamma-interferon on carcinoembryonic antigen expression of human colon cancer cells, J Immunother 11) [2], Seite 77-84..

Yannelli, J. R.; Hyatt, C.; McConnell, S.; Hines, K.; Jacknin, L.; Parker, L.; Sanders, M. und Rosenberg, S. A. (1996): Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience, Int J Cancer 65) [4], Seite 413-21.

Yeatman, T. J.; Bland, K. I.; Copeland, E. M., 3rd und Kimura, A. K. (1989): Tumor cell-surface galactose correlates with the degree of colorectal liver metastasis, J Surg Res 46) [6], Seite 567-71.

Yew, N. S.; Wysokenski, D. M.; Wang, K. X.; Ziegler, R. J.; Marshall, J.; McNeilly, D.; Cherry, M.; Osburn, W. und Cheng, S. H. (1997): Optimization of plasmid vectors for high-level expression in lung epithelial cells, Hum Gene Ther 8) [5], Seite 575-84..

Yip, S.; Aboody, K. S.; Burns, M.; Imitola, J.; Boockvar, J. A.; Allport, J.; Park, K. I.; Teng, Y. D.; Lachyankar, M.; McIntosh, T.; O'Rourke, D. M.; Khoury, S.; Weissleder, R.; Black, P. M.; Weiss, W. und Snyder, E. Y. (2003): Neural stem cell biology may be well suited for improving brain tumor therapies, Cancer J 9) [3], Seite 189-204.

Yodoi, J.; Teshigawara, K.; Nikaido, T.; Fukui, K.; Noma, T.; Honjo, T.; Takigawa, M.; Sasaki, M.; Minato, N.; Tsudo, M. und et al. (1985): TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells), J Immunol 134) [3], Seite 1623-30.

Yoneda, N.; Tatsumi, E.; Kawano, S.; Teshigawara, K.; Oka, T.; Fukuda, M. und Yamaguchi, N. (1992): Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT, Leukemia 6) [2], Seite 136-41.

Yun, C. O.; Nolan, K. F.; Beecham, E. J.; Reisfeld, R. A. und Junghans, R. P. (2000): Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors, Neoplasia 2) [5], Seite 449-59.

Zenner, G.; Vorherr, T.; Mustelin, T. und Burn, P. (1996): Differential and multiple binding of signal transducing molecules to the ITAMs of the TCR-zeta chain, J Cell Biochem 63) [1], Seite 94-103.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: